Food and Drug Administration
Novel approaches to support therapeutic development in ultra-rare cancers
Novel approaches to support therapeutic development in ultra-rare cancers is a funding opportunity from Food and Drug Administration.
Overview
The purpose of this program is to support new approaches that can be applied to facilitate therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common cancers. Specific areas of interest include, but are not limited to, the following examples:•…